Dr Graham Ruecroft has spent over 25 years in industry including senior positions with Enzymatix, Chiroscience, Chirotech Technology, DowPharma and Ultrafine. He is co-founder and former director and CTO at Prosonix Ltd where he was inventor on all Prosonix patents and participated fully in Series A and B financing rounds. He has an extensive understanding of chemical processing and ultrasonication in biotechnology.

Dr Steve Taylor has a proven track record in industrial biocatalysis in the pharmaceutical and chemical industry including holding senior positions with Enzymatix, Chiroscience, Chirotech Technology and DowPharma. He founded Enzagen Ltd (enzyme supply) and has been instrumental in establishing and growing the biocatalysis technology base of Almac Sciences, which now has one of the most prominent biocatalysis groups in the UK.

Dr Clive Rankin has broad international experience in executive management across a variety of industries and is a business angel, adviser and non-executive director to small businesses. He was formerly Divisional Chairman of Laporte and Vice President of Degussa, before operating freelance in private equity (Lancea Partners). He brings a broad business experience in both small and large companies together with his network in private equity.